FutureFemHealth

🔥 Here’s your catch-up on everything women’s health innovation and FemTech from the last week.⁣ Read all of these stories in our weekly newsletter www.futurefemhealth.com ⁣ 📌 World-first for IVF tech 'Fertilo' by Gameto as baby is born from eggs matured outside the body ⁣ 📌 Tween period care company RedDropCo wins Pharrell Williams’ $1m Black Ambition grand prize. ⁣ 📌 Unfabled launches own-brand supplement range in UK pharmacy retail store Boots. | Hannah Samano 📌 Asan launches period tracking app that also tracks your carbon footprint | Ira Guha 📌 Bettii Pod secures £400,000 in investment and Scottish Edge funding | Elaine Galston ⁣ 📌 Fertility start-up Lushi launches to transform the IVF experience with at-home injection support. | Jessica Schaefer ⁣ 📌 FemPulse Corporation wins FDA investigational device exemption (IDE) to use overactive bladder vaginal ring in pivotal trial | Alexandra Haessler, MD ⁣ 📌 WellTheory launches women’s health program to address link between autoimmune disease and hormonal imbalances | Ellen Rudolph ⁣ 📌 Kindbody CEO Gina Bartasi steps down (again). 📌 National Institutes of Health launches women’s health research website. ⁣ 📌 Women's pain 'dismissed' in UK, warns damning parliamentary report ⁣ 📌 White House hosts its first conference on women’s health research ⁣ 📌 Jobs! ⁣ And even more! Link in bio to read and subscribe, if you want! 🥳

Of the more than 50 million Americans who suffer from an autoimmune disease, eighty percent are women, with certain conditions being 16 times more common. A new program from WellTheory will support women navigating the bidirectional link between autoimmune disease and hormone imbalances such as PCOS, endometriosis, postpartum, hypothyroidism, perimenopause, menopause, and more. “As a woman who began suffering with an autoimmune disease in my mid-20’s, who went on to learn that multiple hormonal issues were one of the root causes of my diagnosis, it was important to create a program aimed at helping other women navigate this oftentimes long and frustrating journey to get find solutions.” Ellen Rudolph, CEO and co-founder. Full story: https://lnkd.in/e4xbMggy _____________________________________ 📩 Want a free round-up of women's health innovation and FemTech news like this each week? Join 7,600+ others on the FutureFemHealth mailing list here: https://lnkd.in/dTrt-yYd  _____________________________________

Female-led biotech company Gameto has announced the world’s first live human birth using ‘Fertilo’, its technology that matures eggs outside the body. The delivery was conducted at Santa Isabel Clinic, in Lima, Peru. Traditional IVF relies on nearly two weeks worth of injections to help stimulated hormones and mature eggs - placing a significant burden on the person attempting to get pregant. Instead, Fertilo recreates the egg maturation process in a lab setting using engineered ovarian support cells (OSCs). This replaces up to 80% of the hormone injections required with traditional IVF and reduces treatment cycles to just three days. The result is a more comfortable and less invasive experience for patients. "Fertilo provides a potentially faster, safer, and more accessible solution for families. This milestone marks a turning point in reproductive health" Dina Radenkovic Turner, CEO and co-founder. Read our full story: https://lnkd.in/e67eY8vp

Menstrual cup company Asan has launched a free period tracking app. It includes a unique environmental tracker, enabling women to track the carbon footprint of their period products. "Our environmental tracker is all about driving behaviour change. In the UK, we flush 2 billion tampons per year and the number is billions more worldwide. By giving users an easy way to track the carbon footprint of their period products in real time, we hope to drive up adoption of reusable options like Asan cups and period underwear." Ira Guha, founder of Asan Full story: https://lnkd.in/e6dvxgxn

Earlier this month our co-founder Clio Wood was back on BBC Radio 4's Woman's Hour hosted by Nuala McGovern with Tess Isabelle Cosad of Béa Fertility and Farah K. of HANX to talk about our CensHERship work once again. Our first report shows that 9 in 10 organisations experience censorship of women's health content (organic and paid) on social media and 100% of the organisations surveyed in our second piece of research experienced refusal or difficulties with financial services. This censorship extends to ecommerce and payments platforms too, but perhaps more worryingly also to banking and insurance - fundamental administration that businesses need to operate. This suppression means that the whole life cycle of women's health and femtech businesses (the vast majority of which are female-founded) is negatively impacted. As most of these businesses are tackling traditionally under-served and under-researched women's health problems, it ultimately means that the gender health gap is being sustained. We'd love to talk to Amazon and Meta for starters (the two companies we mentioned in our case studies) but everyone is welcome to come and chat to see how CensHERship can help you help us all make some change! Get in touch via our website: www.censhership.co.uk Link to listen in the comments!

🚀Calling All Femtech Innovators to apply for the 2025 Tech4Eva program 🌟 Do you have a disruptive Femtech solution and are ready to accelerate your growth, gain global visibility, and make an impact? Join the Tech4Eva Accelerator — our 6-month virtual, global program designed to propel your Femtech start-up to new heights! 94 alumni already went through the program and raised more than $200 Million to date. For our 5th cohort, we are looking for 10-15 groundbreaking solutions making an impact improving women's health in areas such as: 🍼 Pregnancy & Postpartum 🧠 Mental Health & Wellbeing 🩸 Period Health 🧬 Fertility & Infertility 🤷♀️ Endometriosis 🍑 Sexual & Pelvic Health 🎗️ Oncology 🔥 Menopause Care 🩺 Prevention & Treatment 💀 Bone & Brain Health ❤️ Immune & Heart Diseases Tech4Eva welcomes innovations from all stages and regions! 🌍 🗓️ Deadline to Apply: February 15, 2025 👉 Apply Here: https://hubs.ly/Q02_ggHl0 Groupe Mutuel EPFL Innovation Park #Femtech #Tech4Eva #Womenshealth #Innovation #Startups #Healthtech #digitalhealth #medtech #womenshealthmatters

Women’s health and wellness platform Unfabled has today launched a nationwide partnership with Boots UK, the UK’s leading health and beauty retailer to bring Unfabled Essentials, the platform’s supplement line, to 50 Boots UK stores nationwide. Boots customers will be able to shop Unfabled supplements by symptom including bloating, period pain, poor sleep and anxiety. The range includes six Unfabled Essentials products in capsule and gummy form. The range has been developed using data from Unfabled’s dedicated consumer insights and research platform ‘Unfabled Labs’. “With the power of Unfabled Labs, we can create products women actually need, and we’re thrilled to see such demand for our Essentials range, now available nationwide in Boots." Hannah Samano Founder and CEO Unfabled Read our full story: https://lnkd.in/ed92XPmF

Women's pain is 'dismissed' in the UK, warns a new parliamentary report from the Women and Equalities Committee, out today. The report calls for: - more training for healthcare professionals - better education in schools - more trusted online information - better monitoring of routine healthcare procedures - long-term, ring-fenced funding and resource for the women’s health hub model - greater investment in research funding Read our full story here: https://lnkd.in/e5uU2HH5 _____________________________________ 📩 Want a free round-up of women's health innovation and FemTech news like this each week? Join 7,600+ others on the FutureFemHealth mailing list here: https://lnkd.in/dTrt-yYd  _____________________________________

🔥 Here’s your catch-up on everything women’s health innovation and FemTech from the last week.⁣ ⁣ All of these stories are free to read in our weekly newsletter www.futurefemhealth.com ⁣ 📌 The $15.7 billion call to action for women’s health research that would transform the The National Institutes of Health | Sheila Burke Alina Salganicoff ⁣ 📌 NUA SURGICAL raises €6.5 million for C-section device. | Barry Mc Cann Marie-Therese Maher Padraig Maher ⁣ 📌 ConTIPI Medical Ltd Medical launches pelvic organ prolapse device ‘ProVate’ | Elan Ziv, MD OBGYN FPMRS 📌 New scoring system accurately predicts coronary risk in women. 📌 FDA-cleared wearable device Bone Health Technologies | Osteoboost for osteopenia treatment opens for pre-orders | Laura Yecies Michael Jaasma ⁣ 📌 Babyscripts ride-share program with Lyft saved expectant mothers time, money. ⁣ 📌 ShiraTronics, Inc. initiates pivotal trial for its neuromodulation therapy for chronic migraine. ⁣ 📌 Influencers selling fake cures for polycystic ovary syndrome, says BBC World Service ⁣ 📌 Jobs! ⁣ And even more! 🥳 ⁣

Existing pessaries for pelvic organ prolapse are associated with a high drop-off rate for use, and reusuable devices tend to be difficult for most users to insert and remove. ConTIPI Medical Ltd has launched 'ProVate' specifically designed to be ready-to-use quickly and easily within the comfort and privacy of home. Full story: https://lnkd.in/e-2-NrB3